The issue of asymmetrical growth in Specialised Biotechnology Firms in the USA and the UK

International Journal of Biotechnology

Volumn 9, Issue 1, 2007, Pages 87-100

  Bas, Tomas Gabriel ^a   Niosi, Jorge ^b  

^a UNIVERSIDAD ADOLFO IBÁÑEZ   (Chile)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Alliances; Canada; Competence and resource based theories of the firm; Human health; Patents; SBFs; Specialised Biotechnology Firms; UK; Unequal growth; USA; Venture capital

Indexed keywords

HEALTH CARE; INDUSTRIAL ECONOMICS; INDUSTRIAL ENGINEERING; MARKETING; MERGERS AND ACQUISITIONS;

HUMAN HEALTH; SPECIALISED BIOTECHNOLOGY FIRMS (SBF); UNEQUAL GROWTH; VENTURE CAPITALS;

BIOTECHNOLOGY;

BIOTECHNOLOGY; DATABASE; HEALTH AND SAFETY; INDUSTRIAL DEVELOPMENT; JOINT VENTURE; REGRESSION ANALYSIS;

ARTICLE; BIOTECHNOLOGY; ECONOMIC DEVELOPMENT; FINANCIAL MANAGEMENT; HEALTH STATUS; HUMAN; INDUSTRY; MARKETING; UNITED KINGDOM; UNITED STATES;

CANADA; EURASIA; EUROPE; NORTH AMERICA; UNITED KINGDOM; UNITED STATES; WESTERN EUROPE;

EID: 34248366536     PISSN: 09636048     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJBT.2007.012170     Document Type: Article

References (18)

1. Acs, Z. and Audretsch, D. (1990) Innovation and Small Firms, Cambridge, MA: MIT Press.
2. Audretsch, D. (1995) Innovation and Industry Evolution, Cambridge, MA: MIT Press.
3. Baldwin, J. (1999) Innovation, Training and Success, Ottawa: Statistics Canada, Micro-Economic Analysis Division.
4. Christensen, C. (1997) The Innovator's Dilemma, Boston: Harvard Business School Press.
5. Foss, N.J. (2000) 'Equilibrium versus evolution in the resource-based perspective: the conflicting legacies of Demsetz and Penrose', in N.J. Foos and P.L. Robertson (Eds.) Resources, Technology and Strategy, London: Routledge, pp.11-30.
6. Foss, N.J. and Knudsen, C. (Eds.) (1996) Towards a Competence Theory of the Firm, London: Routledge.
7. Hamel, G. and Prahalad, C.K. (1994) Competing for the Future, Boston: Harvard Business School Press.
8. Kenney, M. (1986) Biotechnology the University Industrial Complex, New Haven: Yale University Press.
9. Leonard-Barton, D. (1998) Wellsprings of Knowledge, Boston: Harvard Business School Press.
10. Nelson, R.R. (1994) 'Why do firms differ and how does it matter?', in R. Rumelt et al. (Eds.), Fundamental Issues in Strategy, Boston: Harvard Business School Press.
11. Niosi, J. (2003) 'Alliances are not enough. Explaining rapid growth in biotechnology firms', Research Policy, Vol. 32, pp.737-750.
12. Niosi, J. and Bas, T.G. (2001) 'The competencies of regions. Canada's clusters in biotechnology', Small Business Economics, Vol. 17, pp.31-42.
13. Penrose, E. (1959) The Theory of the Growth of the Firm, Oxford: Basil Blackwell.
14. Ryan, A., Freeman, J. and Hybels, R. (1995) 'Biotechnology firms', in G.R. Carroll, M.T. Hannan, (Eds.) Organizations in Industry, Oxford: Oxford University Press, pp.232-258.
15. Swan, P.G., Prevezer, M. and Stout, D. (Eds.) (1998) The Dynamics of Industrial Clustering, Oxford: Oxford University Press.
16. Teece, D., Pisano, G. and Shuen, A. (1997) 'Dynamic capabilities and strategic management', Strategic Management Journal, Vol. 18, pp.509-534.
17. Wernerfelt (1984) 'A resource-based view of the firm', Strategic Management Journal, Vol. 5, pp.171-180.
18. Zucker, L., Darby, M. and Brewer, M.B. (1998) 'Intellectual human capital and the birth of U.S. biotechnology enterprise', American Economic Review, Vol. 88, pp.290-306.